The global Cancer Biomarkers Market, valued at USD 13.21 billion in 2022, is anticipated to witness substantial growth, with forecasts projecting a rise to USD 36.89 billion by 2030. This growth is expected to occur at a robust compound annual growth rate (CAGR) of 13.7% during the forecast period spanning from 2023 to 2030.Cancer biomarkers are molecular indicators found in blood, tissue,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek